论文部分内容阅读
我国医药行业是由中西药品、医疗器械、卫生材料、制药机械、医药包装材料等工业和医药商业,以及医药科研、教育、设计所组成的产业群体。 医药行业担负着为人民防病治病、康复保健、救灾防疫、军需战备和计划生育提供医药产品的责任,具有重大的社会效益;同时,医药又是高科技、国际化产业,具有显著的经济效益。 改革开放以来,我国以相当的规模,强劲的发展势头,跻身于世界医药大国行列,以其工商统一、生产经营科研教育设计齐备的完整体系,成为国民经济的一个重要组成部分。 一、全行业医药工业企业从1978年的1275家,增加到1994年的7200多家。其中化学制药2000家,中药852家,医疗器械和卫生材料2500家,药用包装材料和容器1731家,制药机械54家。职工150万人。固定资产原值由1978年的20亿元,增加到1994年的400多亿元,增长19倍。大中型企业600家,国有企业和大中型企业产值均占医药工业总产值的65％以上。
China’s pharmaceutical industry is an industrial group composed of Chinese and Western pharmaceuticals, medical devices, sanitary materials, pharmaceutical machinery, pharmaceutical packaging materials and other industrial and pharmaceutical businesses, as well as pharmaceutical scientific research, education, and design. The pharmaceutical industry is responsible for providing people with medical products for disease prevention and treatment, rehabilitation and health care, disaster relief and epidemic prevention, military readiness and family planning, and has significant social benefits. At the same time, medicine is a high-tech and internationalized industry with a significant economy. benefit. Since the reform and opening up, China has become a major country in the world with a considerable scale and strong development momentum. It has become an important part of the national economy with its complete system of industrial and commercial integration, production, scientific research, education, and design. 1. The number of pharmaceutical industry enterprises in the entire industry increased from 1,275 in 1978 to more than 7,200 in 1994. There are 2,000 chemical and pharmaceutical products, 852 Chinese medicines, 2,500 medical and sanitary materials, 1731 medical packaging materials and containers, and 54 pharmaceutical machinery. 1.5 million employees. The original value of fixed assets increased from 2 billion yuan in 1978 to more than 40 billion yuan in 1994, an increase of 19 times. There are 600 large and medium-sized enterprises. The output value of state-owned enterprises and large and medium-sized enterprises account for more than 65% of the total value of the pharmaceutical industry.